Skip to Content

Cogstate Ltd COGZF

Morningstar Rating
$0.81 −0.04 (5.02%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

COGZF is trading at a 23% discount.
Price
$0.81
Fair Value
$1.56
Uncertainty
Very High
1-Star Price
$1.35
5-Star Price
$6.62
Economic Moat
Pljp
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if COGZF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.81
Day Range
$0.810.82
52-Week Range
$0.701.21
Bid/Ask
$0.79 / $0.85
Market Cap
$138.24 Mil
Volume/Avg
6,731 / 28,811

Key Statistics

Price/Earnings (Normalized)
28.01
Price/Sales
3.84
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
2.01%

Company Profile

Cogstate Ltd is a cognitive science company. The principal activity of the company is the sale of technology and services for the measurement of cognition, where services include scientific consultancy, project management, data management, statistical analysis, and reporting. Its operating segment includes Clinical Trials; Healthcare and Research. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.
Sector
Healthcare
Industry
Health Information Services
Stock Style Box
Small Core
Total Number of Employees
380

Comparables

Valuation

Metric
COGZF
301333
688253
Price/Earnings (Normalized)
28.0140.8852.01
Price/Book Value
3.832.922.64
Price/Sales
3.847.1310.38
Price/Cash Flow
325.0425.0934.10
Price/Earnings
COGZF
301333
688253

Financial Strength

Metric
COGZF
301333
688253
Quick Ratio
2.8718.25
Current Ratio
3.2418.83
Interest Coverage
74.18349.72
Quick Ratio
COGZF
301333
688253

Profitability

Metric
COGZF
301333
688253
Return on Assets (Normalized)
12.25%4.47%
Return on Equity (Normalized)
18.04%4.81%
Return on Invested Capital (Normalized)
17.02%4.51%
Return on Assets
COGZF
301333
688253
See how this stock stacks up to its competitors with Morningstar Investor

Health Information Services Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
GEHC
GE HealthCare Technologies Inc Common StockZxpwj$38.8 Bil
VEEV
Veeva Systems Inc Class ACcbtxxkygYxtt$32.2 Bil
SOLV
Solventum CorpRcbnhx$11.1 Bil
MTHRF
M3 IncYqwhn$8.3 Bil
MTHRY
M3 Inc ADRGbtwxv$8.3 Bil
HQY
HealthEquity IncVnzpwr$6.9 Bil
PMCUF
Pro Medicus LtdDmpxsg$6.9 Bil
RCM
R1 RCM IncBzbq$5.1 Bil
DOCS
Doximity Inc Class AWlbtw$4.6 Bil
TXG
10x Genomics Inc Ordinary Shares - Class AZdqn$3.4 Bil

Sponsor Center